How does TSMR.F's PE Ratio compare to its peers?

TSMR.F is good value based on its Price-To-Earnings Ratio (14.6x) compared to the peer average (17x).

How does TSMR.F's PE Ratio compare vs other companies in the US Pharmaceuticals Industry?

TSMR.F is good value based on its Price-To-Earnings Ratio (14.6x) compared to the US Pharmaceuticals industry average (18.9x).

What is TSMR.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate TSMR.F's Price-To-Earnings Fair Ratio for valuation analysis.

What is the Fair Price of TSMR.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

TSMR.F ($28.15) is trading below our estimate of [[fair value]] ($36.53)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

TSMR.F Stock Overview

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally. More details

TSMR.F fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	1/6
Past Performance	5/6
Financial Health	6/6
Dividends	4/6

Rewards

Trading at 22.9% below our estimate of its fair value

Earnings are forecast to grow 7.07% per year

Earnings grew by 85.4% over the past year

Risk Analysis

Shares are highly illiquid

Dividend of 2.81% is not well covered by free cash flows

My Notes

Capture your thoughts, links and company narrative

Tsumura & Co. Competitors

Supernus Pharmaceuticals

NasdaqGM:SUPN

US$2.0b

Amphastar Pharmaceuticals

NasdaqGS:AMPH

US$1.9b

Prestige Consumer Healthcare

NYSE:PBH

US$3.9b

Organon

NYSE:OGN

US$3.8b

Price History & Performance

Summary of share price highs, lows and changes for Tsumura
Historical stock prices
Current Share Price	JP¥28.15
52 Week High	JP¥28.15
52 Week Low	JP¥18.75
Beta	0.10
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-2.27%
5 Year Change	n/a
Change since IPO	46.23%

Recent updates

Shareholder Returns

	TSMR.F	US Pharmaceuticals	US Market
7D	0%	-0.3%	-2.7%
1Y	n/a	7.9%	23.4%

Return vs Industry: Insufficient data to determine how TSMR.F performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how TSMR.F performed against the US Market.

Price Volatility

Is TSMR.F's price volatile compared to industry and market?
TSMR.F volatility
TSMR.F Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.6%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.9%
10% least volatile stocks in US Market	3.2%

Stable Share Price: TSMR.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine TSMR.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1893	4,138	Terukazu Kato	www.tsumura.co.jp

Tsumura & Co. manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally. The company offers Kampo extract intermediates, granular and prescription Kampo formulations, over-the-counter Kampo medicine, other medications, and herbal bath salts. It offers its products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation, hemorrhoid, body aches, cold, cough, nasal/throat inflammation, children's sickness, stress, and urinary problems.

Tsumura & Co. Fundamentals Summary

How do Tsumura's earnings and revenue compare to its market cap?
TSMR.F fundamental statistics
Market cap	US$2.39b
Earnings (TTM)	US$164.18m
Revenue (TTM)	US$1.07b

14.6x

P/E Ratio

2.2x

P/S Ratio

Is TSMR.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TSMR.F income statement (TTM)
Revenue	JP¥164.61b
Cost of Revenue	JP¥84.35b
Gross Profit	JP¥80.26b
Other Expenses	JP¥55.06b
Earnings	JP¥25.20b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 06, 2025

Earnings per share (EPS)	331.92
Gross Margin	48.76%
Net Profit Margin	15.31%
Debt/Equity Ratio	22.0%

How did TSMR.F perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

36%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/18 21:39
End of Day Share Price	2024/09/20 00:00
Earnings	2024/09/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tsumura & Co. is covered by 18 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
null null	Company Forecast
Fumiyoshi Sakai	Credit Suisse
Kazuaki Hashiguchi	Daiwa Securities Co. Ltd.